Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIMAZ 20 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DIMAZ 20 MG/ML COLIRIO EN SOLUCION

Approved

STANDARD

DIMAZ 20 MG/ML COLIRIO EN SOLUCION

Brill Pharma S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 19, 2022
Approval ID: 5f8c0cebf6834f59
Company: Brill Pharma S.L.
Type: Standard

Approval Details

Approval Id: 5f8c0cebf6834f59
Drug Cima Aemps Name: DIMAZ 20 MG/ML COLIRIO EN SOLUCION
Register Number: 86764
Holder Company Name: Brill Pharma S.L.
Marketing Company Name: Brill Pharma S.L.
Authorization Date: 2022-05-19
Dosage Form: COLIRIO EN SOLUCIÓN
Dose: 20 mg/ml
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Brill Pharma S.L.

Active Ingredients

DORZOLAMIDA HIDROCLORURO

22,26 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 19, 2022

Approval ID

5f8c0cebf6834f59

Type

Standard

Back to CIMA-AEMPS Approvals